Report cover image

Livestock Vaccines Market

Publisher Fortune Business Insights Pvt. Ltd.
Published Oct 01, 2024
Length 150 Pages
SKU # FOB19224133

Description

Livestock Vaccines Market



Growth Factors of Livestock Vaccines Market

The global livestock vaccines market size was valued at USD 5.73 billion in 2023 and is projected to grow from USD 6.01 billion in 2024 to USD 9.80 billion by 2032, exhibiting a CAGR of 6.3% during the forecast period of 2024-2032.

However, the COVID-19 outbreak affected the production and supply of farm animal vaccines, focusing on zoonotic diseases further, revitalizing the emphasis on animal fitness, and accelerating market recovery, which hindered the livestock vaccines market growth.

The market for cattle vaccines is growing due to the increase in demand for meal merchandise from animals, increasing frequency of poverty among farm animals, augmented awareness of the health of animals, and initiatives given by the governments to encourage vaccines for stopping diseases amongst farm animals.

Personalized vaccines are a growing fashion within the cattle vaccines market. Advancements in the vaccine era enable the improvement of vaccines tailored to unique pathogens or animal genotypes, imparting more excellent robust safety in opposition to sicknesses and expanding the livestock vaccines market share globally. By concentrating on particular ailment editions or individual animal traits, personalized vaccines can offer a more custom-designed and effective ailment prevention technique, contributing to livestock populations' general fitness and well-being.

Comprehensive Analysis of Livestock Vaccines Market

The livestock vaccines market is segmented by kind, animal type, direction of administration, and distribution channel. The stay attenuated vaccines section led to growing disorder outbreaks and robust immune responses. The bovine phase is dominated by animal type, while the fowl segment is predicted to increase. Parenteral management has turned into the leading direction because of its reliability, with oral administration showing a sturdy boom potential. Veterinary clinics held the most crucial distribution channel share, supported via improved animal visits and vaccine adoption, while veterinary hospitals are also anticipated to see a considerable increase.

The North America region led the livestock vaccines market by benefitting a size of USD 2.68 billion in 2023 due to the growth in vaccine launches through marketplace players, the area is anticipated to dominate the global market percentage.

The leading livestock vaccine market players significantly shape its growth trajectory and set industry standards. Key companies, including Boehringer Ingelheim International GmbH (Germany), Virbac (France), Merck Animal Health (Merck & Co., Inc.) (U.S.), Zoetis Services LLC (U.S.), Ceva (France), Elanco (U.S.), HIPRA (Spain), and Neogen Corporation (U.S.), contribute to a highly competitive landscape, driving innovation and market development.

In December 2023, The private limited chain subsidiary of the NDDB, Indian Immunologicals Ltd (IIL), found that its most promising innovative vaccines in the pipeline are for the IBR ache and lumpy skin disease in conjunction with an advocacy mixture for rabies prevention.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 6.3% from 2024-2032

Unit Value (USD billion)

Segmentation

By Type
  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others
By Animal Type
  • Bovine
  • Swine/ Porcine
  • Poultry
  • Others
By Route of Administration
  • Oral
  • Parenteral
  • Others
By Distribution Channel
  • Veterinary Hospitals
  • Veterinary Clinics
  • Others
By Geography
  • North America (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country)
  • U.S.
  • Canada
  • Europe (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
  • Asia Pacific (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
  • China
  • India
  • Japan
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
  • Latin America (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region
  • Brazil
  • Mexico
  • Rest of the Latin America
  • Middle East & Africa (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

150 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Veterinary Vaccination Rates: Key Conditions
4.2. Overview on Vaccination Programs
4.3. Key Industry Developments, Mergers, Acquisitions, Partnerships, etc.
4.4. Impact of COVID-19 Pandemic on Livestock Vaccines Market
5. Global Livestock Vaccines Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Type
5.1.1. Inactivated
5.1.2. Live Attenuated
5.1.3. Recombinant
5.1.4. Others
5.2. Market Analysis, Insights and Forecast – By Animal Type
5.2.1. Bovine
5.2.2. Swine/ Porcine
5.2.3. Poultry
5.2.4. Others
5.3. Market Analysis, Insights and Forecast – By Route of Administration
5.3.1. Oral
5.3.2. Parenteral
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By Distribution Channel
5.4.1. Veterinary Hospitals
5.4.2. Veterinary Clinics
5.4.3. Others
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Livestock Vaccines Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Type
6.1.1. Inactivated
6.1.2. Live Attenuated
6.1.3. Recombinant
6.1.4. Others
6.2. Market Analysis, Insights and Forecast – By Animal Type
6.2.1. Bovine
6.2.2. Swine/ Porcine
6.2.3. Poultry
6.2.4. Others
6.3. Market Analysis, Insights and Forecast – By Route of Administration
6.3.1. Oral
6.3.2. Parenteral
6.3.3. Others
6.4. Market Analysis, Insights and Forecast – By Distribution Channel
6.4.1. Veterinary Hospitals
6.4.2. Veterinary Clinics
6.4.3. Others
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Livestock Vaccines Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Type
7.1.1. Inactivated
7.1.2. Live Attenuated
7.1.3. Recombinant
7.1.4. Others
7.2. Market Analysis, Insights and Forecast – By Animal Type
7.2.1. Bovine
7.2.2. Swine/ Porcine
7.2.3. Poultry
7.2.4. Others
7.3. Market Analysis, Insights and Forecast – By Route of Administration
7.3.1. Oral
7.3.2. Parenteral
7.3.3. Others
7.4. Market Analysis, Insights and Forecast – By Distribution Channel
7.4.1. Veterinary Hospitals
7.4.2. Veterinary Clinics
7.4.3. Others
7.5. Market Analysis, Insights and Forecast – By Country/Sub-region
7.5.1. United Kingdom
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Livestock Vaccines Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Type
8.1.1. Inactivated
8.1.2. Live Attenuated
8.1.3. Recombinant
8.1.4. Others
8.2. Market Analysis, Insights and Forecast – By Animal Type
8.2.1. Bovine
8.2.2. Swine/ Porcine
8.2.3. Poultry
8.2.4. Others
8.3. Market Analysis, Insights and Forecast – By Route of Administration
8.3.1. Oral
8.3.2. Parenteral
8.3.3. Others
8.4. Market Analysis, Insights and Forecast – By Distribution Channel
8.4.1. Veterinary Hospitals
8.4.2. Veterinary Clinics
8.4.3. Others
8.5. Market Analysis, Insights and Forecast – By Country/Sub-region
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Livestock Vaccines Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Type
9.1.1. Inactivated
9.1.2. Live Attenuated
9.1.3. Recombinant
9.1.4. Others
9.2. Market Analysis, Insights and Forecast – By Animal Type
9.2.1. Bovine
9.2.2. Swine/ Porcine
9.2.3. Poultry
9.2.4. Others
9.3. Market Analysis, Insights and Forecast – By Route of Administration
9.3.1. Oral
9.3.2. Parenteral
9.4. Market Analysis, Insights and Forecast – By Distribution Channel
9.4.1. Veterinary Hospitals
9.4.2. Veterinary Clinics
9.4.3. Others
9.5. Market Analysis, Insights and Forecast – By Country/Sub-region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa Livestock Vaccines Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Type
10.1.1. Inactivated
10.1.2. Live Attenuated
10.1.3. Recombinant
10.1.4. Others
10.2. Market Analysis, Insights and Forecast – By Animal Type
10.2.1. Bovine
10.2.2. Swine/ Porcine
10.2.3. Poultry
10.2.4. Others
10.3. Market Analysis, Insights and Forecast – By Route of Administration
10.3.1. Oral
10.3.2. Parenteral
10.4. Market Analysis, Insights and Forecast – By Distribution Channel
10.4.1. Veterinary Hospitals
10.4.2. Veterinary Clinics
10.4.3. Others
10.5. Market Analysis, Insights and Forecast – By Country/Sub-region
10.5.1. South Africa
10.5.2. GCC
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. Boehringer Ingelheim International GmbH
11.2.1.1. Overview
11.2.1.2. Products & Services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Virbac
11.2.2.1. Overview
11.2.2.2. Products & Services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Merck Animal Health (Merck & Co., Inc.)
11.2.3.1. Overview
11.2.3.2. Products & Services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. Zoetis Services LLC
11.2.4.1. Overview
11.2.4.2. Products & Services
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Ceva
11.2.5.1. Overview
11.2.5.2. Products & Services
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. Elanco
11.2.6.1. Overview
11.2.6.2. Products & Services
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Nisseiken Co., Ltd.
11.2.7.1. Overview
11.2.7.2. Products & Services
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. Neogen Corporation
11.2.8.1. Overview
11.2.8.2. Products & Services
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us